Ovarian cancer statistics

Boehringer Ingelheim

Ovarian cancer is caused by abnormal and uncontrolled growth of cells from the tissues of the female ovaries. Each year approximately 225,484 new cases of ovarian cancer are diagnosed in women worldwide, with an estimated 140,153 dying of the disease each year.¹ One of the greatest challenges in the management of ovarian cancer is that the majority of cases are not found at an early stage² when cure would be possible by surgery. Thus far, there exists no screening algorithm to achieve earlier diagnoses, which would make higher cure rates more feasible. Therefore, for the time being, more effective and tolerable treatments to achieve long-term remissions in the advanced-stages of the disease are warranted.

1. Ferlay J et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010; [Epub ahead of print].

2. Boyle P et al. World Cancer Report. International Agency for Research on Cancer 2008.

Source for healthcare professionals: www.inoncology.com
* Nintedanib (BIBF 1120), afatinib (BIBW 2992) and volasertib (BI 6727) are investigational compounds. Their safety and efficacy have not yet been fully established.

† Not an official event of the 2012 ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the Conquer Cancer Foundation.

Boehringer Ingelheim on